Phase I clinical trial of Innocell a novel tumor specific immunotherapy (a therape utic vaccine) targeting triple-negative breast cancer
Latest Information Update: 19 Aug 2021
At a glance
- Drugs Cancer vaccine-PhotonPharma (Primary)
- Indications Triple negative breast cancer
- Focus Adverse reactions
- 19 Aug 2021 New trial record
- 11 Aug 2021 According to a Terumo BCT media release, the PhotonPharma is currently preparing an Investigational New Drug (IND) submission related to a phase I clinical trial targeting triple-negative breast cancer.